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Prepared for the CPACS Methamphetamine Treatment Facility Feasibility Study

By
R.K. Piper
Jerry Diechert
Center for Public Affairs Research

INTRODUCTION
This internal report has been prepared as part of the larger Methamphetamine
Treatment Facility Feasibility Study conducted by the College of Public Affairs and
Community Services for the Nebraska State Legislature. The major purposes of this
report are as follows: 1) to integrate previously submitted working findings and tables
into a single “stand-alone” document and 2) to provide an overview and context for the
findings that will be useful to technical writers, faculty, staff and graduate assistants who
are responsible for preparing the final report for the legislature.
Methodology and Research Questions
This cost study has been guided from the outset by a series of research questions
developed to systematically identify existing gaps in methamphetamine/amphetaminerelated treatment services in Nebraska and to provide cost estimates for programs and
facilities to meet identified needs. Table A. summarizes the major research questions, as
well as the data sources and published reports consulted in their investigation.
Table A.
Methamphetamine Treatment-Facility Cost Research Questions and Data
Sources/Published Reports Consulted
Major Study Areas

Research Questions

Published/Internal
Reports & Data Sources
(National/States)

Substance- Abuse
Treatment Needs
and Costs

1. What is the total prevalence
(population) of illicit-drug, stimulantrelated and meth-amphetamine related
substance abusers in NE?

1. “State Estimates of Substance Use from the 2002-2003
National Suverys on Drug Use and Health,” SAMHSA
(2004).

a. Of these, how many are
receiving treatment (met demand)?
b. How many need but are not in
treatment?

“Substance Abuse Treatment Admissions by State and
Primary Substance of Abuse,” SAMHSA (2003).
“Analysis of Substance Abuse Prevalence, Treatment
Resources and Gaps in Colorado,” State of Colorado
(2002).

c. How many want or would seek
treatment if it was available (unmet
demand)?

Substance-Abuse
Treatment Facility
Costs

2. What are the average costs for
drug treatment by level of treatment
(e.g., for residential and outpatient
levels)?

2. “DATStats: Results from 85 studies using the Drug
Abuse Treatment Cost Program Analysis (DATCAP), by
M.C. Roebuck et al, Journal of Drug Abuse Treatment
(2003).

What are the estimated treatment
costs to meet the unmet demand of
those who are not receiving
treatment, but want or would seek
treatment?

“State Estimates of Substance Use from the 2002-2003
National Suverys on Drug Use and Health,” SAMHSA
(2004).

1. What types and how many
facilities currently provide substance
abuse treatment in NE?

1. “National Survey of Substance Abuse Treatment
Services (N-SSATS) State Profile Nebraska,” SAMHSA
(2003).
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Substance-Abuse
Treatment Facility
Costs (continued)
Impacts of
Substance-Abuse
Treatment on State
Budgets

a. What are the fixed costs for these
types of treatment facilities?

a. (Pending master budgets, audited facility, performance
reports to be provided by the State of Nebraska.)

b. What are the combined fixed and
variable (treatment program) costs
for each type?

b. “DATStats: Results from 85 studies using the Drug
Abuse Treatment Cost Program Analysis (DATCAP), by
M.C. Roebuck et al, Journal of Drug Abuse Treatment
(2003).
1. “Shoveling Up: The Impact of Substance Abuse on
State Budgets,” National Center on Addiction and
Substance Abuse at Columbia (CASA), (2001).

1. What portion of the Nebraska
State Budget is currently devoted to
dealing with the impacts of substance
abuse?
a. What are the major areas of state
spending that are most impacted by
substance abuse?

“Nebraska Department of Correctional Services (DCS)
FY-2004 Annual Report and Statistical Summary.”

b. What portion of state spending is
devoted to substance abuse treatment
and prevention?
c. How does this compare to
surrounding states?
d. How does this compare to the
national average?

Summary and Cost Estimation Models Based on Findings
Based on the information collected and analyzed, estimated gaps in substance
abuse treatment services in Nebraska are illustrated by type of drug in four concentric
circles in Figures 1-3. Cost estimates if the total unmet demand were met at any
single level of treatment are also shown in the figures for five of the six levels of
treatment identified in the report. Additional estimates for alternative combinations of
residential and outpatient treatment are provided in Section V. of the report.
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Figure 1.
Gaps in Substance Abuse Treatment Services—Any Illicit Drug-Related
Would seek
treatment
(Unmet
demand)
In treatment
(Met demand)
Not in treatment

Total prevalence

2,981
5,678
59,617
65,295

Total unmet demand

2,981 persons

Estimated cost to meet unmet demand at any single level of treatment
Residential
$12.8 million
Therapeutic community
$25.6 million
Standard outpatient
$ 2.9 million
Intensive outpatient
$ 6.0 million
Drug court
$ 4.7 million
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Figure 2.
Gaps in Substance Abuse Treatment Services—Stimulant-Related
Would seek
treatment
(Unmet
demand)
In treatment
(Met demand)
Not in treatment

Total prevalence

1,985
3,781
39,705
43,486

Total unmet demand

1,985 persons

Estimated cost to meet unmet demand at any single level of treatment
Residential
$12.8 million
Therapeutic community
$25.6 million
Standard outpatient
$ 2.9 million
Intensive outpatient
$ 6.0 million
Drug court
$ 4.7 million
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Figure 3.
Gaps in Substance Abuse Treatment Services—Meth-/Amphetamine-Related
Would seek
treatment
(Unmet
demand)
In treatment
(Met demand)
Not in treatment

Total prevalence

1,359
2,589
27,185
29,774

Total unmet demand

1,359 persons

Estimated cost to meet unmet demand at any single level of treatment
Residential
$12.8 million
Therapeutic community
$25.6 million
Standard outpatient
$ 2.9 million
Intensive outpatient
$ 6.0 million
Drug court
$ 4.7 million
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Uses and Refinement of the Gaps in Treatment and Cost Estimate Model
The findings in the report are presented as a model to estimate gaps in substance
abuse treatment services (especially related to meth-and amphetamine abuse) in Nebraska
and the variable (program) and fixed (facilty) costs to address them. When morecomplete and program-specific data becomes available from the Nebraska Departments
of Health and Human Services (N-HHS) and Correctional Services (DCS) and other
sources, they can be incorporated into the model. Regardless of whether additional data
becomes available, the findings in this report and the model can be used by policymakers and program administrators to better understand the needs for additional drug
treatment services and the costs of providing them.
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MAJOR RESEARCH FINDINGS
The major research findings in this report are presented in the order they were
developed in five areas:
I. Impacts of Substance Abuse on the Nebraska State Budget;
II. Treatment Admissions in Nebraska;
III. Levels of Treatment/Costs at Nebraska Department of Corrections Facilities;
IV. Prevalence of Substance Dependence/Abuse; Users Needing but Not
Receiving Treatment; Unmet Treatment Demand in Nebraska;
V. Cost Estimates for Unmet Treatment Demand in Nebraska.
As requested, key findings have been presented as highlighted bullets and include
summary tables and in-depth working tables (all tables are numbered 1-25 and
working tables in Excel format are identified by file name: for example, State
Spending (NE).xls).
I. IMPACTS OF SUBSTANCE ABUSE ON THE NEBRASKA STATE BUDGET
A review and analysis of Nebraska state budget information conducted in 2001 by
the National Center on Addiction and Substance Abuse at Columbia University (CASA)1
reveals the following key findings (which do not include any Federal or local spending):


The state government of Nebraska spent about $291 million or 8.2% of the
entire annual state budget ($3.5 billion) dealing with the impacts,
regulation/compliance functions and problems of substance abuse. Of this
amount, only about $9 million or .3% was spent by the state on substance
abuse treatment, prevention and research. (See Tables 1-7 for Nebraska and
six surrounding states [State Spending (NE).xls]).



For every dollar the state of Nebraska spends on substance abuse:
o 91 cents goes to pay for the burden of this problem on public
programs in the affected areas of criminal justice,
elementary/secondary education, health, child/family assistance,
mental health/developmental disability, public safety and the state
workforce.
o Only 3.1 cents goes to fund prevention, treatment and research
programs aimed at reducing the incidence and consequences of
substance abuse.

“Shoveling Up: The Impact of Substance Abuse on State Budgets,” by the National Center on Addiction
and Substance Abuse at Columbia (2001) is based on detailed budget data for 1998 submitted by Nebraska
and 46 other state budget officials.
1
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o

The remaining 5.8 cents goes for regulation/compliance of alcohol and
tobacco licensing, control and collection of taxes (compared to a national
average of only .5 cents).2
(Table 1. shows the total spending in each category in Nebraska, the
amount and percentage related to substance abuse and the per capita
amount spent for each person in the state).



Even though state spending on substance abuse cannot be disaggregated by
type of drug (e.g., methamphetamines), nationwide results show that 78.2% is
related to a combination of both illicit drugs and alcohol, while only 11.3%
could be attributed to alcohol only, 9.1% to tobacco only and 1.4% to illicit
drugs only.
Based on these findings, the estimated amount of state spending in Nebraska
linked to abuse of illicit drugs (in combination with and without alcohol) is
about $232 million (79.6% of $291 million). Of this amount, approximately
$225 million goes toward cleaning up the wreckage of illicit drug abuse,
while only about $7 million is applied to illicit drug prevention and
treatment.3

II. TREATMENT OF METHAMPHETAMINE, AMPHETAMINE AND OTHER
STIMULANT ABUSE (NE)
A review and analysis of 2003 SAMSHA substance abuse treatment admissions
data for Nebraska reveals the following key findings:


There were a total of 10,609 admissions for substance abuse treatment; of these,
4,320 were for alcohol only treatment, while 6,289 (64.4%) were for primary
substances other than alcohol or alcohol as a primary substance in
combination with a secondary illicit drug. (See Table 8 [Substance Abuse
Admissions NE.xls] for a complete breakdown of treatment admissions in
Nebraska by primary substance).



Of these 6,289 non-alcohol only admissions, 4,188 (66.6%) were linked to
methamphetamines, amphetamines or other stimulants;4 and after

2

This proportion, amounting to .5% of the state budget, is the highest of all reporting states, matched only
by Alabama and Washington.
3

As all regulation and compliance substance abuse spending is alcohol and tobacco only, the breakdown of
the $232 million illicit-drug (in combination with and without alcohol) spending estimate is based on the
total substance abuse spending ratio of 97:3 affected-program spending to treatment, prevention and
research spending.
This total includes estimates of the number of “alcohol w/secondary drug” and “other/unknown”
classifications which were stimulant-related (cocaine, amphetamines and other stimulants). Alcohol
w/secondary drug estimates were based on the proportion of primary drug admissions which were
4
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eliminating primary and secondary cocaine and other stimulant abusers from this
population, 2,869 (45.6%) were linked to methamphetamines or
amphetamines. (Table 9 [Substance Abuse Admissions NE.xls] shows the
percentages of admissions linked to methamphetamines and other stimulants in
Nebraska and the six surrounding states).


Altogether, the 2,869 admissions linked to methamphetamines and
amphetamines comprise 27.0% of admissions for substance abuse treatment
(alcohol only + non-alcohol only) in Nebraska.

III. LEVELS OF TREATMENT/COSTS AT NEBRASKA DEPARTMENT OF
CORRECTIONS FACILITIES
A review of sections of the 2004 Nebraska Department of Correctional Services
(DCS) annual report related to substance abuse programming and treatment services
reveals the following:


The DCS provides four general levels of care: Residential, Non-Residential,
Assessment and Evaluation and Emergency. Table 10. shows DCS facilities that
offer services at the residential, non-residential and assessment/evaluation levels
and the annual costs per inmate at each facility.

Table 10.
Nebraska Department of Correctional Services Substance Abuse Levels of Care and
Costs by Facility
Level of Care

NE DCS Facility

Long-Term
Residential and
Residential

1. Nebraska State Penitentiary
(100 minimum custody
males at RTC)

NE DCS Substance
Abuse Program
1. Residential Treatment
Community (10 months)

Total Annual Cost
per Inmate
1. $27,834

Parole Violator Program
(90-120 days intensive)
2. Omaha Correctional Center
(72 minimum custody males
at SAU)

2. Substance Abuse Unit
(10 months)

2. $23,389

3. Tecumseh State
Correctional Institution
(32 minimum custody males
at SAU)

3. Substance Abuse Unit
(10 months)

3. $30,923

4. Nebraska Correctional
Center for Women
(28 minimum custody
females at SAU)

4. Substance Abuse Unit
(10 months)

4. $27,423

Parole Violator Program
(90-120 days intensive)

stimulant-related (70.5%), while a somewhat more conservative estimate of 50% stimulant-related was
used for “other/unknown” classifications.
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Non-Residential

Non-Residential
(continued)

Evaluation and
Assessment

1. Nebraska State Penitentiary

1. Education, Intensive
Outpatient, Aftercare

1. n/a

2. Omaha Correctional Center

2. Education, Intensive
Outpatient, Aftercare

2. n/a

3. Tecumseh State
Correctional Institution

3. Education, Intensive
Outpatient, Aftercare

3. n/a

4. Nebraska Correctional
Center for Women

4. Intensive Outpatient,
Aftercare

4. n/a

5. McCook Work Ethic Camp

5. Education, Intensive
Outpatient

5. $15,948 (based on number
of annual admissions)

6. Community Corrections
Center-Lincoln

6. Education, Outpatient,
Aftercare

6. $15,996

7. Community Corrections
Center-Omaha

7. Education, Outpatient,
Aftercare

7. $14,705

8. Lincoln Correctional Center

8. Education, Intensive
Outpatient, Aftercare

8. $32,123

9. Nebraska Correctional
Youth Facility

9. Education, Intensive
Outpatient, Aftercare

9. $68,275

1. Diagnostic and Evaluation
Center

1. Diagnosis, Evaluation,
Assessment, Classification
and Facility Assignment

1. $30,977

2. Nebraska Correctional
Center for Women

2. Diagnosis, Evaluation,
Assessment, Classification
and Facility Assignment

2. n/a

3. Nebraska Correctional
Youth Facility

3. Diagnosis, Evaluation,
Assessment, Classification
and Facility Assignment

3. n/a

IV. LEVELS OF SUBSTANCE DEPENDENCE/ABUSE; USERS NEEDING BUT
NOT RECEIVING TREATMENT; UNMET TREATMENT DEMAND (NE).
A review and analysis of the SAMHSA report “State Estimates of Substance Use
from the 2002-2003 National Surveys on Drug Use and Health”5 reveals the following
key findings:
Substance Abuse and Dependence


A total of 65,295 persons 12 years of age and older (4.6% of that population)
were estimated to be dependent on or abused illicit drugs in Nebraska in
2003.6 (Tables 11-19 [Drug Dependence-Abuse Estimates.xls] show the
estimated ranges of drug dependence and abuse, dependence and persons

5

This SAMHSA report presents state estimates on substance use based on the combined findings of the
2002 and 2003 National Surveys on Drug Use and Health (NSDUHs), formerly called the National
Household Survey on Drug Abuse (NHSDA).
6
This estimate uses 2002-2003 survey results rates applied to 2000 U.S. Census data.
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needing but not receiving treatment in Nebraska and selected counties (Adams,
Douglas, Lancaster, Madison, Red Willow and Scotts Bluff).


When grouped by age, 15,197 were between the ages of 17-25; 22,416 were 1825; and 27,638 were 26 or older.
[The estimate of 65,295 persons is shown as Alternative Estimate B. in table 11.
Base Estimate A. (40,312) is based on the NSDUH surveys findings that showed
2.84% of the population aged 12 years and over reported drug dependence or
abuse in the past 12 months. Alternative Estimate C. (89,425) is based on a
model used by the State of Colorado which increased the NSDUH findings in that
state by 125% (to 7.2%) by factoring in additional state survey data, estimates of
residents without phones, the homeless, recently incarcerated prisoners,
adolescents in juvenile corrections facilities, etc. Alternative Estimate B. is a
mid-point estimate (not exact due to rounding) between estimates A. and B.]
o Of these, 43,486 (66.6% based on SAMHSA admissions data)7 were
estimated to be dependent on or abused stimulant-related illicit drugs
and 29,774 (45.6%) were methamphetamine or amphetamine
dependent or abusers. (See Table 20 for age group estimates
[Dependence-Abuse Cohorts.xls]).

Persons Needing But Not Receiving Treatment


A total of 59,617 persons 12 and over (4.2%) needed but did not receive
treatment for an illicit drug use problem in 2003.8 (Table 21 summarizes the
levels of drug dependence, drug dependence or abuse and numbers of persons
needing but not receiving treatment in Nebraska and selected counties.)



When grouped by age, 13,584 were between the ages of 12-17; 19,822 were 1825; and 26,211 were 26 or older.
[The difference between the estimated numbers of persons 12 years of age and
older in Nebraska who were dependent on or abused any illicit drug (65,295) and
the number who needed but did not receive treatment during the past 12 months
(59,617) is 5,678 (based on the National Surveys on Drug Use and Health
findings). As shown in Section II., SAMHSA treatment admissions data shows
that there were 6,289 admissions linked to illicit drugs in Nebraska in 2003.9

7

NSDUH survey findings are further refined by using SAMSHA treatment admissions data for Nebraska
including estimates of the proportions of “alcohol w/secondary drug” and “other/unknown” classifications
that were stimulant- and methamphetamine/amphetamine-related (see Section II., footnote 4).
8
Persons “needing treatment” are defined as those who are classified as either drug dependent or abusers.
The status of these are based on the criteria specified in the Diagnostic and Statistical Manual of Mental
Disorders (DSM-IV) (American Psychiatric Association, 1994), indicators of which are included in the
survey questions. Those “not receiving treatment” did not receive any during the past 12 months.
9
Treatment admissions may include multiple admissions for the same person.
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These very similar findings using two separate data sources support the validity of
the estimates.]
o Of these, 39,705 stimulant-related (66.6% based on SAMHSA
admissions data) and 27,185 (45.6%) methamphetamine or
amphetamine-related problem users needed but did not receive
treatment. (See Table 22 for age group estimates [Treatment Needs Age
Cohorts.xls]).
Table 20.
Substance Dependence/Abuse and Users Needing But Not Receiving Treatment in
Nebraska and Selected Counties (2003)
STATE/Counties
Total 2000
Drug
Drug
User Needing/
/(Major City)
Population
Dependence Dependence Not Receiving
Or Abuse
Treatment
(Persons 12 yrs.
(Persons in Past

NEBRASKA
Any Illicit Drug
Stimulant-Related Drug
Meth/AmphetamineRelated
Douglas (Omaha)
Any Illicit Drug
Stimulant-Related Drug
Meth/AmphetamineRelated
Lancaster (Lincoln)
Any Illicit Drug
Stimulant-Related Drug
Meth/AmphetamineRelated
Madison (Norfolk)
Any Illicit Drug
Stimulant-Related Drug
Meth/AmphetamineRelated
Adams (Hastings)
Any Illicit Drug
Stimulant-Related Drug
Meth/AmphetamineRelated
Red Willow (McCook)
Any Illicit Drug
Stimulant-Related Drug
Meth/Amphetamine
Related

and over)

Year)

(N)
1,419,450

(N)

(%)

(Persons in Past
Year)

(Persons in Past Year)

(N)

(N)

(%)

(%)

44,395 (3.1)
29,306 (2.1)
20,065 (1.4)

65,295 (4.6)
43,486 (3.1)
29,774 (2.1)

59,617 (4.2)
39,705 (2.8)
27,185 (1.9)

11,818 (3.1)
7,871 (2.1)
5,389 (1.4)

17,537 (4.6)
11,679 (3.1)
7,997 (2.1)

16,012 (4.2)
10,664 (2.8)
7,301 (1.9)

6,540 (3.1)
4,355 (2.1)
2,982 (1.4)

9,704 (4.6)
6,463 (3.1)
4,425 (2.1)

8,860 (4.2)
5,901 (2.8)
4,040 (1.9)

905 (3.1)
603 (2.1)
413 (1.4)

1,344 (4.6)
895 (3.1)
613 (2.1)

1,227 (4.2)
817 (2.8)
559 (1.9)

811 (3.1)
540 (2.1)
370 (1.4)

1,204 (4.6)
802 (3.1)
549 (2.1)

1,099 (4.2)
732 (2.8)
501 (1.9)

299 (3.1)
199 (2.1)
136 (1.4)

444 (4.6)
296 (3.1)
202 (2.1)

405 (4.2)
270 (2.8)
185 (1.9)

381,229

210,953

29,209

26,165

9,646
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Scotts Bluff (Scottsbluff)

30,790

Any Illicit Drug
Stimulant-Related Drug
Meth/Amphetamine
Related

954 (3.1)
636 (2.1)
435 (1.4)

1,416 (4.6)
943 (3.1)
646 (2.1)

1,293 (4.2)
861 (2.8)
590 (1.9)

Unmet Demand for Treatment


Of the 59,617 persons who needed but did not receive treatment, there is an
estimated unmet treatment demand in Nebraska of 2,981 illicit drug, 1,985
stimulant-related and 1,359 methamphetamine- or amphetamine-related
problem users. 10
Unmet treatment demand refers to those persons who are drug dependent or
abusers that “needed but did not receive treatment” and also “wanted or would
seek” treatment if it was available. (Table 23 shows the unmet treatment demand
estimates for Nebraska by age group).
Table 23.
Unmet Treatment Demand Estimates in Nebraska by Age Group (2003)
Population
(12+)

Age 12-17

Age 18-25

26 or Older

Any Illicit Drug

2,981

679

991

1,311

Stimulant-Related

1,985

452

660

873

Meth/AmphetamineRelated

1,359

310

452

598

V. COST ESTIMATES FOR UNMET TREATMENT DEMAND (NE).
A review and application of the cost findings in the study, “Results from 85
studies using the Drug Abuse Treatment Cost Analysis Program (DATCAP),” by M.C.
Roebuck and other economists supported by the National Institute on Drug Abuse
(NIDA) reveals the following key findings:

10

As with the substance abuse/dependence estimates, the extent to which models used in other states
accurately reflect conditions in Nebraska is uncertain (despite the cross-validity evidence cited above). A
State of Colorado model (see “Analysis of Substance Abuse Prevalence, Treatment Resources and
Treatment Gaps in Colorado,” by Bruce Mendelson, 2002) used integrated survey findings to determine
that 2.7% of problem users who did not receive treatment, wanted or would seek treatment if it was
available. To estimate unmet treatment demand in Nebraska we use an alternative estimation rate of 5.0%.
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Residential and Outpatient Treatment Costs


The estimated costs of providing treatment to meet the unmet demand in
Nebraska (those who did not receive, but wanted or would seek treatment if it was
available) varies widely according to the level of treatment or program type.
(Table 24. shows the estimated costs to meet the aggregate unmet demand11 by
type of drug and various alternative levels of residential and outpatient
treatment).
o For example, the total estimated treatment costs12 for the 2,981 persons
who wanted or would seek treatment for any illicit drug problem,
ranged from $5.6 to $68.8 million, as follows:
Residential
 $34.4 million (residential)
 $68.8 million (therapeutic
community)
 $5.6 million (in-prison
therapeutic community) *
Outpatient
 $7.6 million (standard
outpatient)
 $16.3 million (intensive
outpatient)
 $12.7 million (drug court)
o The estimated treatment costs for the 1,985 persons who wanted or would
seek treatment for a stimulant-related drug problem, ranged from $3.0
to $25.6 million, as follows:
Residential
 $18.7 million (residential)
 $37.3 million (therapeutic
community)

11

Aggregate unmet demand refers to gross numbers of persons needing and wanting treatment.
Developing cost estimates for alternative levels of treatment is for illustrative purposes and provides a basic
cost range. These estimates are not based on specific data or assumptions about the proportions of unmet
demand for treatment at particular levels, nor do they address the issues of determining the most
appropriate forms of treatment to meet the unmet demand.
12
DATCAP cost estimates are based on the study of 32 residential and 53 outpatient drug treatment
programs between 1993 and 2002 and include and include both fixed (facility) and variable costs (See
“DATStats: Results from 85 studies using the Drug Abuse Treatment Cost Program Analysis,” by M.C.
Roebuck et al, 2003). The DATCAP data collection instrument is shown in the Appendix which also
includes more-detailed cost and methodology information.
*
Does not include incarceration costs.
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$3.0 million (in-prison
therapeutic community) *

Outpatient
$4.2 million (standard
outpatient)
 $8.8 million (intensive
outpatient)
 $6.9 million (drug court)


o The estimated treatment costs for the 1,359 persons who wanted or would
seek treatment for a methamphetamine/amphetamine drug problem,
ranged from $2.1 to $25.6 million, as follows:
Residential
$12.8 million (residential)
$25.6 million (therapeutic
community)
 $2.1 million (in-prison
therapeutic community) *



Outpatient
$2.9 million (standard
outpatient)
 $6.0 million (intensive
outpatient)
 $4.7 million (drug court)


*
*

Does not include incarceration costs.
Does not include incarceration costs.
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Table 24.
Cost Estimates for Unmet Demand by Level of Treatment in Nebraska (2003)
LEVEL OF TREATMENT/
PROGRAM TYPE
(Average Duration)

Average 18 Years
Cost per or Older
Treatment
($ Millions)
Episode

Ages
12-17

Total*
Age 12+

($ Millions)

($ Millions)

[2,302]

[679]

[2,981]

$9,426

$28.1

N/A

N/A

$9,347

N/A

$6.3

N/A

Any Illicit Drug
[Persons]
RESIDENTIAL
Adult Residential
(13 weeks)
Adolescent Residential
(8 weeks)
Total Adult and Adolescent
Residential
Therapeutic Community
(33 weeks)
Therapeutic Community (Prison)**
(28 weeks)
OUTPATIENT
Standard Adult Outpatient
(17 weeks)
Standard Adolescent Outpatient
(13 weeks)
Total Adult and Adolescent
Standard Outpatient
Intensive Outpatient
(7 weeks)
Drug Court
(46 weeks)

$34.4
$18,802

$56.0

$12.8

$68.8

$1,534

$4.6

$1.0

$5.6

$1,944

$5.8

N/A

N/A

$2,678

N/A

$1.8

N/A
$7.6

$4,445

$13.2

$3.0

$16.3

$3,463

$10.3

$2.4

$12.7

[1,533]

[452]

[1,985]

Stimulant-Related Drug
[Persons]
RESIDENTIAL
Adult Residential
(13 weeks)
Adolescent Residential
(8 weeks)
Total Adult and Adolescent
Residential
Therapeutic Community
(33 weeks)
Therapeutic Community (Prison)**
(28 weeks)
OUTPATIENT
Standard Adult Outpatient
(17 weeks)
Standard Adolescent Outpatient
(13 weeks)
Total Adult and Adolescent
Standard Outpatient

$9,426

$14.4

$9,347

$4.2
$18.7

$18,802

$28.8

$8.5

$37.3

$1,534

$2.4

$.7

$3.0

$1,944

$3.0

$2,678

$1.2
$4.2
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Intensive Outpatient
(7 weeks)
Drug Court
(46 weeks)

$4,445

$6.8

$2.0

$8.8

$3,463

$5.3

$1.6

$6.9

[1,049]

[310]

[1,359]

Meth/Amphetamine-Related
[Persons]
RESIDENTIAL
Adult Residential
(13 weeks)
Adolescent Residential
(8 weeks)
Total Adult and Adolescent
Residential
Therapeutic Community
(33 weeks)
Therapeutic Community (Prison)**
(28 weeks)
OUTPATIENT
Standard Adult Outpatient
(17 weeks)
Standard Adolescent Outpatient
(13 weeks)
Total Adult and Adolescent
Standard Outpatient
Intensive Outpatient
(7 weeks)
Drug Court
(46 weeks)

$9,426

$9.9

$9,347

$2.9
$12.8

$18,802

$19.7

$5.8

$25.6

$1,534

$1.6

$.5

$2.1

$1,944

$2.0

$2,678

$.8
$2.9

$4,445

$4.7

$1.4

$6.0

$3,463

$3.6

$1.1

$4.7

* Estimates shown in 2001 dollars. Columns may not add due to rounding.
**Does not include incarceration costs
Unmet Demand by Levels of Treatment
According to National Survey of Substance Abuse Treatment Services (NSSATS) data for 2003, about 85% of clients in treatment in Nebraska received
outpatient, 14% received residential and 1% hospital inpatient. While the proportions
of unmet demand at each level of treatment are currently unknown, it is possible to
illustrate alternative unmet demand cost estimates through a combination of
residential and outpatient treatment options.
Combined Residential-Outpatient Treatment Cost Illustrations


The estimated costs of providing treatment to meet the unmet demand in
Nebraska (as shown in Table 24) are based on “stand alone” residential and
outpatient program classifications. Alternative programs might be developed to
address a specific problem, such as methamphetamine addiction, through a
combination of residential and outpatient treatment programming.
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(Table 25. illustrates the estimated costs three such possible combinations:
residential-intensive outpatient, residential-standard outpatient, and residentialdrug court).13
Table 25.
Cost Estimates for Unmet Demand by
Combined Residential and Outpatient Levels of Treatment in Nebraska (2003)
COMBINED
LEVELS OF
TREATMENT
OPTIONS*
Any Illicit Drug

18 Years or
Older

Ages
12-17

Total**
Age 12+

($ Millions)

($ Millions)

($ Millions)

[Persons]
Residential (50%)
Intensive Outpatient
(50%)
Residential (Full)
Standard Outpatient
(50%)
Residential (50%)
Drug Court (50%)

[2,302]

[679]

[2,981]

$20.6

$4.7

$25.3

$31.0

$7.3

$38.2

$19.2

$4.4

$23.6

[1,533]

[452]

[1,985]

$10.6

$3.1

$13.8

$15.9

$4.8

$20.8

$9.9

$2.9

$12.8

[1,049]

[310]

[1,359]

$7.3

$2.1

$9.4

$10.9

$3.3

$14.2

$6.8

$2.0

$8.8

Stimulant-Related
[Persons]
Residential (50%)
Intensive Outpatient
(50%)
Residential (Full)
Standard Outpatient
(50%)
Residential (50%)
Drug Court (50%)

Meth/AmphetamineRelated [Persons]
Residential (50%)
Intensive Outpatient
(50%)
Residential (Full)
Standard Outpatient
(50%)
Residential (50%)
Drug Court (50%)

* Residential-intensive outpatient and residential-drug court cost estimates assume
50% reductions in both duration and costs of residential, intensive outpatient and drug

13

Residential-intensive outpatient and residential-drug court cost estimates assume 50% reductions in both
duration and costs of residential, intensive outpatient and drug court programs as shown in Table 24.
Residential-standard outpatient estimates assume full residential and 50% standard outpatient duration and
costs.
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court programs as shown in Table 24. Residential-standard outpatient estimates
assume full residential and 50% standard outpatient duration and costs.
** Estimates shown in 2001 dollars. Columns may not add due to rounding.
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